{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001001187","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me1","EXPERIMENT_ID":"EGAX00001231900","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["7 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me1"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["#BP140"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 µl"],"EXPERIMENT_TYPE":["Histone H3K4me1"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["0,2 µg"],"CHIP_ANTIBODY_LOT":["A1863-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 µl"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin, antibody and A/G magnetic beads. Wash twice with buffer 1, and once with buffer 2 and 3, and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["-121"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor NGS (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Venous_blood/S00B1L/Chronic_lymphocytic_leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"1.1M","NAME":"S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.bb","FILE_TYPE":"CS_MACS_TRACK_BROAD_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Venous_blood/S00B1L/Chronic_lymphocytic_leukemia/ChIP-Seq/NCMLS/S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.bb","PROTOCOL_DOC":"chip_seq","MD5":"868936d7aeaf92a7b51f4b7814ed838e"},{"FORMAT":"BED","SIZE":"1.6M","NAME":"S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.bed.gz","FILE_TYPE":"CS_BROAD_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Venous_blood/S00B1L/Chronic_lymphocytic_leukemia/ChIP-Seq/NCMLS/S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.bed.gz","PROTOCOL_DOC":"chip_seq","MD5":"3b44da59f86538cfa71fa8e767331e95"},{"FORMAT":"Text","SIZE":"1.8M","NAME":"S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.xls.gz","FILE_TYPE":"CS_BROAD_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Venous_blood/S00B1L/Chronic_lymphocytic_leukemia/ChIP-Seq/NCMLS/S00B1LH1.H3K4me1.ppqt_macs2_broad_v2.20141014.xls.gz","PROTOCOL_DOC":"chip_seq","MD5":"e2d540c8a6592802e5625cc471a3090f"},{"FORMAT":"bigWig","SIZE":"1.1G","NAME":"S00B1LH1.H3K4me1.wiggler.20141014.bw","FILE_TYPE":"CS_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Venous_blood/S00B1L/Chronic_lymphocytic_leukemia/ChIP-Seq/NCMLS/S00B1LH1.H3K4me1.wiggler.20141014.bw","PROTOCOL_DOC":"chip_seq","MD5":"6fb6570bc4d61be5940c101341f4ab4b"}],"dataset_id":"EGAD00001001187","sample":{"SAMPLE_SOURCE":"Venous blood","SAMPLE_NAME":"S00B1L","sample_barcode":"S00B1LH1","attributes":{"DONOR_HEALTH_STATUS":["Chronic lymphocytic leukemia"],"DONOR_AGE":["75-80"],"MOLECULE":["genomic DNA"],"DISEASE":["Chronic lymphocytic leukemia"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["Venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C0023434","label":"C0023434"}],"DONOR_ID":["S00B1L"],"DONOR_SEX":["Unknown"],"DONOR_ETHNICITY":["Caucasian"],"COLLECTION_METHOD":["Venipuncture"],"PASSAGE_IF_EXPANDED":["NA"],"TISSUE_DEPOT":["NA"]},"SAMPLE_ID":"EGAN00001202787","SAMPLE_DESCRIPTION":"Chronic lymphocytic leukemia"}}